Vertex Pharmaceuticals Newsroom

Vertex Pharmaceuticals Analyst Ratings

BenzingaJun 27 17:47

Redburn Atlantic Initiates Vertex Pharmaceuticals at Buy With $545 Price Target

MT NewswiresJun 27 17:21

Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $500 From $456, Maintains Overweight Rating

MT NewswiresJun 26 00:15

Vertex Pharmaceuticals Analyst Ratings

BenzingaJun 24 21:02

Wells Fargo Adjusts Price Target on Vertex Pharmaceuticals to $555 From $540

MT NewswiresJun 24 18:18

Vertex Pharmaceuticals Analyst Ratings

BenzingaJun 18 01:07

Argus Adjusts Price Target on Vertex Pharmaceuticals to $550 From $465

MT NewswiresJun 17 19:57

Vertex Pharmaceuticals Analyst Ratings

BenzingaJun 11 19:37

RBC Adjusts Price Target on Vertex Pharmaceuticals to $421 From $424

MT NewswiresJun 11 17:25

RBC Capital Reiterates Sector Perform on Vertex Pharmaceuticals, Maintains $424 Price Target

BenzingaJun 4 21:55

Vertex Pharmaceuticals Analyst Ratings

BenzingaJun 4 21:50

BMO Capital Maintains Outperform on Vertex Pharmaceuticals, Raises Price Target to $500

BenzingaMay 31 21:45

Vertex Pharmaceuticals Analyst Ratings

BenzingaMay 31 21:45

Wells Fargo Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)

TipRanksMay 28 18:46

Analysts Offer Insights on Healthcare Companies: Cooper Co (COO), Vertex Pharmaceuticals (VRTX) and Guardant Health (GH)

TipRanksMay 27 20:30

Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497

MT NewswiresMay 14 17:48

Stifel Nicolaus Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX)

TipRanksMay 9 10:07

Vertex Pharmaceuticals Sell Rating Maintained Amid Unsustainable Performance and Uncertain Pipeline Progress

TipRanksMay 8 19:35

Sell Rating on Vertex Pharmaceuticals Amid Non-Recurring Gains and Overstated Sales

TipRanksMay 8 12:40

Oppenheimer Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)

TipRanksMay 7 20:20